DAWNIELLE MILLER: Open Payments
NPI 1730706011 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,552 in 182 payments from 14 companies in 2025. Trend: 2023 $2,345 · 2024 $2,061 · 2025 $2,552
Food & beverage: $2,451Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 25 | $388 |
| Janssen Pharmaceuticals, Inc | 21 | $360 |
| Lundbeck LLC | 24 | $355 |
| Alkermes, Inc. | 21 | $300 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $237 |
| Otsuka America Pharmaceutical, Inc. | 11 | $229 |
| Neurocrine BioSciences, Inc. | 12 | $186 |
| ABBVIE INC. | 18 | $154 |
| E.R. Squibb & Sons, L.L.C. | 10 | $154 |
| Vanda Pharmaceuticals Inc. | 4 | $91 |
Products named: INVEGA SUSTENNA, ARISTADA, ABILIFY MAINTENA, CAPLYTA, INGREZZA, ABILIFY ASIMTUFII, REXULTI, VRAYLAR.
Industry payments across OH — which companies pay providers there.
